Search Results
Found 2 results
510(k) Data Aggregation
(307 days)
Indications for FES waveform:
- Stimulation of the muscles in the leg and ankle of partially paralyzed patients to provide flexion of the foot and thus improve the patient's gait.
Indications for TENS waveform:
- Symptomatic relief of chronic (long term) intractable pain
- Symptomatic relief of post-traumatic acute pain and post surgical pain
Indications for Russian waveform:
- Temporary relaxation of muscle spasms
- Prevention or retardation of disuse atrophy in post-injury type conditions
- Increase local blood circulation
- Muscle re-education
- Maintaining or increasing range of motion
The device NEURODYN II is a four output channel stimulator, operated in power supply 100 to 240 V, 50-60 Hz, with independent controls, graphic display backlit blue, mechanical contact keyboard and ABS cabinet with acrylic cover.
Used in the following electrical current therapies: TENS (Transcutaneous Electrical Nerve Stimulation) FES (Functional Electrical Stimulation) RUSSIAN CURRENT (Burst Modulated Medium Frequency)
Characteristics:
TENS: four 120mA peak to peak channels FES: four 120mA peak to peak channels RUSSIAN: four 120mA peak to peak channels Electrical Feed: 100 a 240V (50/60Hz) Input Power: 85VA Temperature Range During Transport and Storage: 41 to 122°F Environment Operating Temperature Range: 41 to 113°F
The device NEURODYN COMPACT is a two output channel stimulator. operated in power supply 100 to 240 V, 50-60 Hz, with independent controls, graphic display backlit blue, mechanical contact keyboard and ABS cabinet with acrylic cover.
Used in the following electrical current therapies: TENS (Transcutaneous Electrical Nerve Stimulation) FES (Functional Electrical Stimulation) RUSSIAN CURRENT (Burst Modulated Medium Frequency)
Characteristics:
TENS: four 120mA peak to peak channels FES: four 120mA peak to peak channels RUSSIAN: four 120mA peak to peak channels Electrical Feed: 100 a 240V (50/60Hz) Input Power: 85VA Temperature Range During Transport and Storage: 41 to 122°F Environment Operating Temperature Range: 41 to 113°F
The provided submission for the NEURODYN Compact and NEURODYN II devices does not include a detailed study proving the devices meet specific quantitative acceptance criteria. Instead, it relies on demonstrating substantial equivalence to previously cleared predicate devices (K121369 Neurodyn/Aussie Powered Muscle Stimulator by Ibramed and K021100 300 PV Complete Electrotherapy System by EMPI) based on similar indications for use, operating principles, hardware configuration, and compliance with recognized electrical safety and performance standards.
The acceptance criteria are implicitly defined by compliance with these standards and the established performance characteristics of the predicate devices.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria | NEURODYN Compact / NEURODYN II Performance |
---|---|
Safety Standards | IEC 60601-1 (General requirements for basic safety and essential performance) |
IEC 60601-1-2 (Electromagnetic compatibility) | |
IEC 60601-1-4 (Programmable electrical medical systems) | |
IEC 60601-2-10 (Nerve and muscle stimulators) | |
Material | Biocompatibility (FDA cleared electrodes) |
Electrical Output Parameters | |
(Demonstrated to be "similar" or "identical" to predicate devices) | TENS: 0-120mA peak to peak |
FES: 0-120mA peak to peak | |
Russian: 0-120mA peak to peak | Reported as identical to K121369 for FES and Russian, and similar to K021100 for TENS (K021100 TENS is 0-50mA peak to peak, K121369 TENS is 0-120mA peak to peak). Given the new devices also have TENS 0-120mA, they are aligned with K121369. |
Frequency | 0.5-250 Hz |
Phase Duration | 50-500μs |
Current Output (at various loads) | 124 mA @ 500Ω, 110mA @ 2KΩ, 39.2mA @ 10KΩ (for Compact/II) |
Charge per Phase | 58μC |
Max. avg. power density | 0.038W/cm² |
Patient Leakage Control | Normal Condition: 0.0347 mA |
Single Fault Condition: 0.0162 mA | Reported values are within acceptable limits per safety standards and comparable to predicate devices. (K121369: 0.0508mA normal, 0.0252mA single fault; K021100: 0.0502mA normal, 0.0248mA single fault). The new devices show lower leakage, indicating better safety performance. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The submission does not describe a test set involving patient data or clinical trials. The "testing results" mentioned are non-clinical and relate to engineering and electrical safety compliance. Therefore, there is no sample size for a test set or information on data provenance in the context of clinical performance.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. The submission focuses on non-clinical engineering and safety standard compliance, not clinical interpretation or ground truth established by medical experts for a diagnostic or treatment outcome.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable, as there is no clinical test set requiring expert adjudication.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a powered muscle stimulator, not an AI-assisted diagnostic or imaging device. No MRMC study was performed or mentioned.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This device is a physical medical device, not an algorithm, and its performance inherently involves human-in-the-loop (e.g., a therapist or patient operating the device).
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The "ground truth" in this context is adherence to recognized international electrical safety and performance standards (IEC 60601 series). These standards define acceptable electrical characteristics, safety mechanisms, and electromagnetic compatibility. The device's performance is measured against the specifications of these standards and comparison to predicate devices, rather than clinical outcomes or expert consensus on patient data.
8. The sample size for the training set
Not applicable. There is no training set mentioned, as this is not an AI/machine learning device.
9. How the ground truth for the training set was established
Not applicable, as there is no training set.
Ask a specific question about this device
(175 days)
Neurodyn Multiwave - Indications for Use:
As a FES device:
- Stimulation of the muscles in the leg and ankle of partially paralyzed patients to provide flexion of the foot and thus improve the patient's gait.
As a TENS device: - Symptomatic relief of chronic (long term) intractable pain
- Symptomatic relief of post-traumatic acute pain and post-surgical pain
As an Interferential and Premodulated device: - Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain
As a Russian device: - Temporary relaxation of muscle spasms
- Prevention or retardation of disuse atrophy in post-injury type conditions
- Increase local blood circulation
- Muscle re-education
- Maintaining or increasing range of motion
As a Burst Modulated Alternating Current (Aussie) device: - Temporary relaxation of muscle spasms
- Prevention or retardation of disuse atrophy in post-injury type conditions
- Increase local blood circulation
- Muscle re-education
- Maintaining or increasing range of motion
- Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain
As a Microcurrent device: - Symptomatic relief of chronic intractable pain
- Symptomatic relief of post-traumatic acute pain and post surgical pain
As a DC/Polarized device: - Relaxation of Muscle Spasm
Aussie Sport - Indications for Use:
As an Burst Modulated Alternating Current (Aussie) device:
- Temporary relaxation of muscle spasms
- Prevention or retardation of disuse atrophy in post-injury type conditions
- Increase local blood circulation
- Muscle re-education
- Maintaining or increasing range of motion
- Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain
Neurodyn Multiwave and Aussie Sport Neuromuscular Stimulators are intended for the treatment of, relief of chronic (long term) intractable pain as adjunctive treatment of post-surgical and post-traumatic acute pain. Both devices have the same intended uses and incorporate the same technologies as the following predicate devices: Vectra Genisys K031077, Neurodyn/Neurpdun Aussie K121369 and 400PV Complete K021100.
The Neurodyn Multiwave Muscle Stimulator is a programmable device. It comes equipped with 5 preset clinical programs along with 10 user programs are adjustable and can be changed according to the patient's needs, doctor's recommendations and prescription settings.
The Aussie Sport Muscle Stimulator has four output channels with independent intensity controls. Thus, four different areas can be stimulated separately or together during a therapy session. It is adjustable and can be changed according to the patient's needs, doctor's recommendations and prescription settings. It generates the medium frequency alternate current(MFAC), burst modulated alternating current (Aussie)- type of sinusoidal current with a frequency carrying 1,000 Hz or 4,000 Hz and a burst duration of 4 ms or 2 ms, modulated in pulse trains (bursts) with a variable frequency from 1 to 120Hz.
The provided document is a 510(k) Summary for the Neurodyn Multiwave and Aussie Sport powered muscle stimulators. It focuses on demonstrating substantial equivalence to previously cleared predicate devices rather than presenting a study with specific acceptance criteria and performance metrics for the device itself.
Therefore, the following information cannot be extracted from the document:
- A table of acceptance criteria and the reported device performance: The document does not define specific performance acceptance criteria for the Neurodyn Multiwave or Aussie Sport devices, nor does it report their performance against such criteria. Instead, it relies on demonstrating that the device characteristics are "identical" to predicate devices.
- Sample size used for the test set and the data provenance: No test set or associated data provenance is mentioned.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: No experts or ground truth establishment are discussed.
- Adjudication method for the test set: No adjudication method is mentioned as there is no test set described.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, an effect size of how much human readers improve with AI vs without AI assistance: No MRMC study or AI assistance is mentioned.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: No standalone algorithm performance is discussed.
- The type of ground truth used: No ground truth is specified.
- The sample size for the training set: No training set is mentioned.
- How the ground truth for the training set was established: No training set or ground truth establishment is discussed.
Summary of Device Comparison (as provided in the document - not an acceptance criteria table):
The document provides a "Device Comparison Table" to show substantial equivalence, not to present acceptance criteria and performance. The key points from this table are:
Feature/Criterion | Neurodyn Multiwave (K131629, New Device) | Predicate Devices (Neurodyn K121369, 300 PV K021100, Vectra Genisys K031077) & Aussie Sport (K131629, New Device) |
---|---|---|
Technological characteristics | Identical | Identical (Medium-frequency alternating current - MFAC) |
Device Material | ABS plastic panel, LCD display | ABS plastic panel, LCD display |
Width (in) | 6.8 | Varied (6.8, 9.75, 1.26) |
Height (in) | 4.9 | Varied (4.9, 3.3, 8.75) |
Depth (in) | 12.4 | Varied (12.4, 12.75, 4.5) |
Number of Channels | 4 | 4 |
Temperature range during transport and storage | 45°f-110°f | Varied (45°f-110°f, -40 to 158°F, -40 to 150 F) |
Environment operating temperature range | 45°F-110°F | Varied (45°F-110°F, 50° to 104°F, 45 to 105° F) |
Performance | Identical | Identical |
Biocompatibility | FDA cleared electrodes | FDA cleared electrodes |
Mechanical Safety | Identical | Identical |
Anatomical Sites | Identical | Identical |
Russian Current | Yes | Yes (Neurodyn, Vectra Genisys); No (300 PV, Aussie Sport) |
Aussie Current | Yes | Yes (Neurodyn, Vectra Genisys, Aussie Sport) |
Interferential Current | Yes | Yes (Neurodyn, 300 PV, Vectra Genisys); No (Aussie Sport) |
Microcurrent | Yes | Yes (Neurodyn, Vectra Genisys); No (300 PV, Aussie Sport) |
TENS | Yes | Yes (Neurodyn, 300 PV, Vectra Genisys); No (Aussie Sport) |
Premodulated | Yes | Yes (Neurodyn, 300 PV, Vectra Genisys); No (Aussie Sport) |
FES | Yes | Yes (300 PV, Vectra Genisys); No (Neurodyn, Aussie Sport) |
DC/Polarized | Yes | Yes (Vectra Genisys); No (Neurodyn, 300 PV, Aussie Sport) |
Voltage Input | 100/240V 50/60Hz Bivolt | Varied (100/240V 50/60Hz Bivolt, 3.0V DC, 100/240V 50/60Hz 1.0A) |
Output | 5A+17V | Varied (5A+17V, 1.0A+3.0V DC, 7.3A+24V) |
Method of line current isolation | Double Isolation | Double Isolation |
Patient leakage control (normal condition) | 0.0508mA | Varied (0.0508mA, 0.0502mA, 69μA) |
Patient leakage current (single fault condition) | 0.0252mA | Varied (0.0252mA, 0.0248mA, 31μA) |
Software microprocessor | Yes | Yes |
Automatic overload trip | No | No |
Automatic shutoff | No | No |
Locking feature | Keyboard lock safety feature | Keyboard lock safety feature |
Treatment timer | 1 to 60 minutes | Varied (1 to 60 minutes, 5 to 60 minutes) |
Auto test and repeat | Treatment timer with auto shut off | Treatment timer with auto shut off / Treatment timer |
Frequency Range | 50/60Hz | Varied (50/60Hz, ---) |
Maximum Current Density | 2.0 mA | 2.0 mA |
Conclusion: The 510(k) summary concludes that the Neurodyn Muscle Stimulators are substantially equivalent to the predicate devices based on similarities in indications for use, technological design, materials, and various performance characteristics. The argument made is that because the new devices are "identical" or sufficiently similar to cleared predicate devices, they do not raise new issues of safety or effectiveness. No specific study demonstrating the new device's performance against defined acceptance criteria is presented.
Ask a specific question about this device
Page 1 of 1